Regulatorisk
Press releases
Press releases
Year
Regulatorisk
Integrum implements new compensation package for its CEO
Icke-regulatorisk
Integrum’s OPRA[TM] Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center
Regulatorisk
A strategic shift to accelerate the commercialization of OPRA® Implant System
Icke-regulatorisk
Integrum AB: Invitation to the Third Quarter 2024/25 Results Presentation
Regulatorisk
Integrum has carried out a directed new issue of 1,937,500 series B shares, raising proceeds of approximately SEK 31 million
Regulatorisk
Integrum explores the conditions to carry out a directed new issue of series B shares of approximately SEK 30 million
Regulatorisk
Integrum publishes preliminary revenue, result and cash flow figures for Q3, 2024/2025
Regulatorisk
Integrum implements strategic shift to accelerate the commercialization of OPRA® Implant System and generate cost efficiencies up to SEK 20 million annually
Icke-regulatorisk
Integrum Partners with SPS to Expand 2025 Education Calendar, Enhancing Learning Opportunities
Icke-regulatorisk
Integrum welcomes new board members
Icke-regulatorisk
Integrum partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes in the US
Loading...